PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-193

  1. 6,009 Posts.
    lightbulb Created with Sketch. 1153
    i don't think we can rule out the possibility of those shorts being a hedge of some form... rather than the traditional money making approach of a shorter wishing for the share price to decline.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.